Goldmans Sachs news from FierceBiotech
News
Biovail focuses on CNS drugs
Development chief outlines strategy at Genentech
CV scores $185M royalty deal on Lexiscan
Circassia pockets $21.8M in second VC round
ALSO NOTED: Nuvelo drug gets fast tracked; QLT brings on Goldman Sachs; and much more...
Biogen Idec in play after Icahn makes his move
AstraZeneca inks $310M deal for asthma programs
ALSO NOTED: Alexza gains $50M; AstraZeneca, Cubist sign $10.25M licensing pact; and much more...
> Symphony Capital Partners will provide $50 million to Alexza Pharmaceuticals for the development of AZ-002 and AZ-004, both of which are in Phase II trials. Release
> Shanghai-based Cathay Industrial Biotech has closed a $52 million second round of financing. Investors include Goldman Sachs, Gramineae Holdings Company Limited, GM Investment Company Limited and New Horizon Evergreen Investment. …
Read more...Merck KGaA buying control of Serono
Germany's Merck KGaA is buying the Bertarelli family's 64.5 percent interest in Switzerland's Serono. The $13.3 billion deal gives the family a 20 percent premium over yesterday's stock price. Serono also announced that its oral cladribine for multiple sclerosis had been fast tracked by the FDA. The family had long signaled its interest in finding a buyer for its stake in the biotech company, but recently had appeared to back off that strategy after failing to put a deal together. Goldman …
Read more...Altana sells drug unit to Nycomed
Germany-based Altana is selling its pharmaceutical business to Denmark's Nycomed for €4.5 billion. Last year Altana hired Goldman Sachs to find a buyer. The company said it would sell the unit due to slow business, high development costs and an inability to compete in the worldwide pharmaceutical market. Altana "has been under pressure ever since mid-2005, when...Pfizer terminated a cooperation to jointly develop respiratory drug Daxas, which Altana hopes will replace sales of its …
Read more...Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets

